1. Preventing Parkinson’s Disease: An Environmental Agenda
- Author
-
E. Ray Dorsey, J. Timothy Greenamyre, Briana R. de Miranda, Gary W. Miller, and Samuel M. Goldman
- Subjects
Parkinson's disease ,Chlorinated solvents ,business.industry ,Parkinson Disease ,Disease ,medicine.disease ,Brain disease ,Cellular and Molecular Neuroscience ,Preclinical research ,Clinical research ,Primary prevention ,Environmental health ,medicine ,Humans ,Disease prevention ,Neurology (clinical) ,Pesticides ,business - Abstract
Fueled by aging populations and continued environmental contamination, the global burden of Parkinson’s disease (PD) is increasing. The disease, or more appropriately diseases, have multiple environmental and genetic influences but no approved disease modifying therapy. Additionally, efforts to prevent this debilitating disease have been limited. As numerous environmental contaminants (e.g., pesticides, metals, industrial chemicals) are implicated in PD, disease prevention is possible. To reduce the burden of PD, we have compiled preclinical and clinical research priorities that highlight both disease prediction and primary prevention. Though not exhaustive, the “PD prevention agenda” builds upon many years of research by our colleagues and proposes next steps through the lens of modifiable risk factors. The agenda identifies ten specific areas of further inquiry and considers the funding and policy changes that will be necessary to help prevent the world’s fastest growing brain disease.
- Published
- 2022
- Full Text
- View/download PDF